Evidence map›Paper›PMID 41620839›Full record

ArticleRespirology (Carlton, Vic.)2026

Addressing the Global Challenges of COPD and Asthma: A Shared Vision From the Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) and the Global Initiative for Asthma (GINA).

David M G Halpin, Refiloe Masekela, Claus F Vogelmeier, Obianuju B Ozoh, Alvaro A Cruz, Helen K Reddel, Arzu Yorgancıoğlu, Alvar Agusti, Boards of Directors of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) and Global Initiative for Asthma (GINA)

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Respirology (Carlton, Vic.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

David M G HalpinFaculty of Health and Life Sciences, University of Exeter Medical School, Exeter, UK.
Refiloe MasekelaDepartment of Paediatrics and Child Health, School of Medicine, College of Health Sciences, University of KwaZulu Natal, Durban, South Africa.
Claus F VogelmeierDepartment of Medicine, Pulmonary and Critical Care Medicine, University Hospital Giessen and Marburg, German Center for Lung Research (DZL), University of Marburg, Marburg, Germany.
Obianuju B OzohDepartment of Medicine, College of Medicine, University of Lagos, Lagos, Nigeria.
Alvaro A CruzFederal University of Bahia and Fundacao ProAR, Salvador, Brazil.
Helen K ReddelWoolcock Institute of Medical Research, Macquarie University, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney School of Public Health, The University of Sydney and Sydney Local Health District, Sydney, New South Wales, Australia.ORCID https://orcid.org/0000-0002-6695-6350
Arzu YorgancıoğluDepartment of Pulmonary Diseases, Celal Bayar University Medical Faculty, Manisa, Turkey.
Alvar AgustiPulmonary Department, Respiratory Institute, Clinic Barcelona, CIBER Enfermedades Respiratorias, Catedra Salud Respiratoria, University of Barcelona, Spain.ORCID https://orcid.org/0000-0003-3271-3788
Boards of Directors of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) and Global Initiative for Asthma (GINA)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

asthmachronic obstructive pulmonary diseasediagnosisGINAGOLDmanagementprevention

Identifiers

PMID41620839
PMCPMC12865516

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.